Changliang Peng

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 03, 2026
Apatinib inhibits synovial sarcoma progression and angiogenesis via VEGFR2-mediated AKT/FOXO3A and ERK1/2/FOXM1 signaling pathways.

|Jul 29, 2025
SPON2 facilitates osteosarcoma development by inducing M2 macrophage polarization through activation of the NF-κB/VEGF signaling axis.

Xinchang Lu, Xueping Zhang, Fengzhen Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Jiazhen Li

1 joint publications

Ruijie Liu